GerosMicro
Financial Marketplace
Investment & Growth Platform
Preparing your investment experience
Initializing platform... 00%
Antengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026
  • prnewswire.com
  • Posted On 09 November 2026

Antengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026

SHANGHAI and HONG KONG, Nov. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global b...
Source: prnewswire.com
Share Now

Live Support

We're here to help

CUSTOMER SUPPORT

Hello! How can we help you?

Send us a message and our Protocol Officer will assist you.

Connecting to support...